396 related articles for article (PubMed ID: 18710463)
1. Use of the Leksell gamma knife in the treatment of prolactinoma patients.
Jezková J; Hána V; Krsek M; Weiss V; Vladyka V; Liscák R; Vymazal J; Pecen L; Marek J
Clin Endocrinol (Oxf); 2009 May; 70(5):732-41. PubMed ID: 18710463
[TBL] [Abstract][Full Text] [Related]
2. Gamma knife radiosurgery for acromegaly--long-term experience.
Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the results of gamma knife radiosurgery for hemangioblastomas of the brain and the factors related to the tumor recurrence].
Wang EM; Wang BJ; Zhang N; Pan L; Dong YF; Zhou LF; Dai JZ; Cai PW; Chen H
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):813-7. PubMed ID: 15200882
[TBL] [Abstract][Full Text] [Related]
4. Gamma knife radiosurgery for medically and surgically refractory prolactinomas.
Pouratian N; Sheehan J; Jagannathan J; Laws ER; Steiner L; Vance ML
Neurosurgery; 2006 Aug; 59(2):255-66; discussion 255-66. PubMed ID: 16883166
[TBL] [Abstract][Full Text] [Related]
5. [Gamma knife treatment for pituitary prolactinomas].
Ma ZM; Qiu B; Hou YH; Liu YS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):714-6. PubMed ID: 17062937
[TBL] [Abstract][Full Text] [Related]
6. Microprolactinomas in males treated by transsphenoidal surgery.
Wolfsberger S; Czech T; Vierhapper H; Benavente R; Knosp E
Acta Neurochir (Wien); 2003 Nov; 145(11):935-40; discussion 940-1. PubMed ID: 14628197
[TBL] [Abstract][Full Text] [Related]
7. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Glaser B; Nesher Y; Barziliai S
J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
Primeau V; Raftopoulos C; Maiter D
Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
[TBL] [Abstract][Full Text] [Related]
10. Factors determining the remission of microprolactinomas after dopamine agonist withdrawal.
Huda MS; Athauda NB; Teh MM; Carroll PV; Powrie JK
Clin Endocrinol (Oxf); 2010 Apr; 72(4):507-11. PubMed ID: 19549247
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up.
Pamir MN; Kiliç T; Belirgen M; Abacioğlu U; Karabekiroğlu N
Neurosurgery; 2007 Aug; 61(2):270-80; discussion 280. PubMed ID: 17762739
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists.
Kars M; Pereira AM; Smit JW; Romijn JA
Eur J Intern Med; 2009 Jul; 20(4):387-93. PubMed ID: 19524180
[TBL] [Abstract][Full Text] [Related]
13. Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
Höfle G; Gasser R; Mohsenipour I; Finkenstedt G
Exp Clin Endocrinol Diabetes; 1998; 106(3):211-6. PubMed ID: 9710362
[TBL] [Abstract][Full Text] [Related]
14. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma.
Tinnel BA; Henderson MA; Witt TC; Fakiris AJ; Worth RM; Des Rosiers PM; Edmondson JW; Timmerman RD; Lo SS
Stereotact Funct Neurosurg; 2008; 86(5):292-6. PubMed ID: 18758206
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
Barber TM; Kenkre J; Garnett C; Scott RV; Byrne JV; Wass JA
Clin Endocrinol (Oxf); 2011 Dec; 75(6):819-24. PubMed ID: 21645021
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
[TBL] [Abstract][Full Text] [Related]
17. Role of gamma knife radiosurgery in the treatment of prolactinomas.
Ježková J; Hána V; Kosák M; Kršek M; Liščák R; Vymazal J; Pecen L; Marek J
Pituitary; 2019 Aug; 22(4):411-421. PubMed ID: 31222579
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of total removal or subtotal removal combined gamma knife radiation on giant pituitary adenoma: a report of 160 cases].
Xiao QH; Huang SQ; Mao BY; Li GP; Ju Y
Ai Zheng; 2007 Jul; 26(7):742-7. PubMed ID: 17626751
[TBL] [Abstract][Full Text] [Related]
19. Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife?
Marek J; Jezková J; Hána V; Krsek M; Bandúrová L; Pecen L; Vladyka V; Liscák R
Eur J Endocrinol; 2011 Feb; 164(2):169-78. PubMed ID: 21071488
[TBL] [Abstract][Full Text] [Related]
20. Influence of parasellar extension of macroprolactinomas defined by magnetic resonance imaging on their responsiveness to dopamine agonist therapy.
Delgrange E; Duprez T; Maiter D
Clin Endocrinol (Oxf); 2006 Apr; 64(4):456-62. PubMed ID: 16584520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]